Thank you!

Your quote has been successfully submitted!

For products requiring additional information, our team will contact you within 1 business day

Failed

There was an error submitting your quote. Please try again.

Recombinant Human IMP1/IMPA1 Protein (His Tag)– MSE Supplies LLC

Free Shipping on MSE PRO Online Orders of $500 or More! U.S. Orders Only * Offer Excludes Hazmat Shipments *

Menu

This product has been added to the cart.

Recombinant Human IMP1/IMPA1 Protein (His Tag)

SKU: PKSH030519-100

  • $ 76995
  • Save $ 8600



Recombinant Human IMP1/IMPA1 Protein (His Tag)

 

SKU # PKSH030519
Expression Host E.coli

 

Description

Synonyms IMP 1, IMPA, IMPA1, IMPase 1, Inositol Monophosphatase 1, Inositol-1(or 4)-Monophosphatase 1, Lithium-Sensitive Myo-Inositol Monophosphatase A1
Species Human
Expression Host E.coli
Sequence Met 1-Asp277
Accession P29218-1
Calculated Molecular Weight 32.4 kDa
Observed Molecular Weight 32 kDa
Tag N-His
Bio-activity Not validated for activity
  

 

Properties

Purity > 85 % as determined by reducing SDS-PAGE.
Endotoxin Please contact us for more information.
Storage Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.
Shipping This product is provided as lyophilized powder which is shipped with ice packs.
Formulation Lyophilized from sterile PBS, 10 % glycerol, pH 7.4
Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.
Reconstitution Please refer to the printed manual for detailed information.


Background

The IMPA1 gene product is responsible for the final step of biotransformation of inositol triphosphate and diacylglycerol, two second messengers. Despite its many physiological functions, no clinical phenotype has been assigned to this gene dysfunction to date. Additionally, IMPA1 is the main target of lithium, a drug that is at the forefront of treatment for bipolar disorder.